KPWHRI is seeking volunteers ages 50 to 64 who have not received this season’s flu vaccine to join the trial.
KPWHRI’s vaccine registry was the first to enroll participants in a clinical trial of a COVID-19 vaccine.
Interim data for the 2023-2024 flu season shows that the vaccine has protected all age groups.
The NIH-sponsored trial will help inform decisions about vaccine approval for 12- to 17-year-olds.
From cardiovascular health to cancer screening, these are the research stories that made headlines over the last year.
Clarissa Hsu, PhD, asked parents why they decline or delay vaccinating their children.
The investigational vaccine is in the third phase of trials and targets flu strains expected to circulate this winter.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.